In-use Cross-over Study of Two Different Menstrual Cups
NCT05411796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2022-06-09
Summary
This study evaluated the safety and tolerability of two different menstrual cups on vaginal health
Conditions
- Menstruation
Interventions
- DEVICE
-
Tampax menstrual cup
regular flow size
- DEVICE
-
Other menstrual cup
size 1
Sponsors & Collaborators
-
Procter and Gamble
lead INDUSTRY
Principal Investigators
-
Michael Noss, M.D. · Synexus, Inc
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-07
- Primary Completion
- 2018-11-14
- Completion
- 2018-11-14
Countries
- United States
Study Locations
More Related Trials
-
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
NCT01198652 ·Status: TERMINATED
-
A Single Group Study to Evaluate the Effects of a Topical Product on Cramps Associated With the Menstrual Cycle
NCT06939972 ·Status: COMPLETED ·Phase: NA
-
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
NCT04272008 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00477633 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Combined Oral Contraceptive Effects in Female Subjects
NCT02157467 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases
NCT04451746 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives
NCT01750476 ·Status: TERMINATED
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CDB-2914 for Emergency Contraception
NCT00411684 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill
NCT01297179 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Oral Contraceptive Pill (OCP)
NCT01063023 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
NCT00236769 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction Study of an OCP (Norethindrone (ND) Acetate and Ethinyl Estradiol (EE))With a Combination of Daclatasvir (DCV) Asunaprevir (ASV) and BMS-791325
NCT02103569 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
NCT06672016 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms
NCT05145257 ·Status: COMPLETED ·Phase: NA
-
Endometrial Safety Study
NCT00522873 ·Status: COMPLETED ·Phase: PHASE3
-
FC Patch Comparator Study
NCT00185354 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT00983957 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
NCT00196313 ·Status: COMPLETED ·Phase: PHASE2
-
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
NCT02824224 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 ·Status: COMPLETED ·Phase: PHASE3
-
Managing Temporomandibular Disorder (TMD) Symptoms
NCT00237042 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Dysmenorrhea
NCT00212342 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED